Licensed from

Mesoglycan (generic name)

treats Atherosclerosis, Vein clots, Intermittent claudication, Chronic venous ulcers, Venous disorders, and Cerebral ischemia
of 4

Aortic acid

Tradition

WARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.
Acrocyanosis (lower limb ischemia), AIDS, allergies, angina (chest pain), anticoagulant (blood thinner), arthritis, autism, blood disorders (impaired plasma fibrinolytic activity), bursitis (inflamed bursa), cancer, circulatory disorders, dementia, gastrointestinal reflux disease, headaches, hemorrhoids, hypercholesterolemia (high cholesterol), immunomodulation, inflammation, kidney stones, macular degeneration (eye disease), obstetric and gynecological disorders, pelvic inflammatory disease, peripheral obstructive arterial disease, skin conditions (cutaneous necrotizing venulitis), ulcerative colitis (inflammatory bowel disease), wound healing

Dosing

Adults (18 years and older):

Mesoglycan is likely safe when taken by mouth in doses less than or equal to 200 milligrams daily for 18 months. There is no proven effective dose. However, 96 or 100 milligrams mesoglycan daily by mouth for six months for cerebrovascular disease and hyperlipidemia (high cholesterol) has been used. For intermittent claudication (leg pain), one 24-milligram mesoglycan tablet twice daily for six months has been used. For phlebitis, two 12-milligram mesoglycan capsules three times a day for 30 days has been used. For postphlebitic syndrome, 50 milligrams mesoglycan twice a day for three months has been used.

Mesoglycan is also likely safe when 90 milligrams is injected for 10 days under the supervision of a qualified healthcare professional, including a pharmacist.

Children (younger than 18 years):

There is no proven safe or effective dose for aortic acid in children.

Safety

DISCLAIMER: Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.

Allergies

There are currently no reported allergic reactions available. Due to the heparan sulfate content of mesoglycan, patients with an allergy to heparin or heparinoid derivatives should use caution.

Side Effects and Warnings

Aortic acid, including mesoglycan, has been well-tolerated for up to 18 months in the available human trials. However, the U.S. Food and Drug Administration (FDA) cautions against the consumption of any dietary supplement made from animal glands or organs, especially from cows and sheep from countries with known cases of bovine spongiform encephalitis (BSE, or "mad cow" disease) or scrapie. It is thought that these extracts may contain viable prions that could infect humans. Currently, there are no available reports of transmission of BSE through aortic acid.

Mesoglycan (injection or taken by mouth) has caused minor side effects including diarrhea, headache.

Use cautiously in patients with coagulation disorders or taking anticoagulation therapy. Use cautiously in patients with an allergy to heparin or heparinoid derivatives.

Use cautiously in patients with hypertension (high blood pressure) or taking antihypertension drugs.

Pregnancy and Breastfeeding

Aortic acid is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence. Although not well studied in humans, hormonal changes may affect aortic acid levels.

of 4

Follow Yahoo Health on and become a fan on

Follow @YahooHealth on